WRBY Warby Parker Inc.
Healthcare$25.51+1.67%ClosedMarket Cap: $3.13B
As of 2026-05-26
Valuation
P/E (TTM)
1581.15
PEG
14.63
P/B
8.24
P/S
3.46
EV/EBITDA
84.31
DCF Value
$-14.31
FCF Yield
1.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
53.4%
Operating Margin
-0.7%
Net Margin
0.2%
ROE
0.4%
ROA
0.2%
ROIC
-0.6%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $242.4M | 54.0% | $1.7M | $3.2M | $— | — |
| Q4 null | $212.0M | 52.4% | $-6.9M | $-6.0M | $— | — |
| FY null | $871.9M | 54.0% | $-5.3M | $1.6M | $— | — |
| Q3 null | $221.7M | 54.1% | $3.6M | $5.9M | $— | — |
| Q2 null | $214.5M | 53.0% | $-4.5M | $-1.8M | $— | — |
| Q1 null | $223.8M | 56.3% | $2.5M | $3.5M | $— | — |
| Q4 null | $190.6M | 54.1% | $-9.4M | $-6.9M | $— | — |
| FY null | $771.3M | 55.3% | $-30.1M | $-20.4M | $— | — |
| Q3 null | $192.4M | 54.5% | $-6.6M | $-4.1M | $— | — |
| Q2 null | $188.2M | 54.0% | $-9.0M | $-6.8M | $— | — |
| Q1 null | $200.0M | 55.0% | $-5.1M | $-2.7M | $— | — |
| Q4 2023 | $161.9M | 53.8% | $-21.6M | $-19.0M | $-0.16 | — |